Success Stories: Research Associate in the Field of Medicinal Chemistry in Florida Received an EB-2 NIW Approval

We Received an EB-2 NIW Approval on July 28th, 2014 for a Research Associate in the Field of Medicinal Chemistry (Approval Notice)


General Field: Medicinal Chemistry

Position at the Time of Case Filing: Research Associate

Country of Origin: India

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing:  Florida

Approval Notice Date: July 28, 2014

Processing Time: 7 months and 12 days

 

 


Case Summary:

For this EB-2 NIW case, we had the privilege of working with aResearch Associate, who has made substantial contributions and garnered international acclaim in the field of Medicinal Chemistry. In his research endeavors, our client has designed, synthesized and evaluated biological and chemical entities, pharmaceutical ingredients, and novel inhibitors of enzyme targets for their ultimate application in the diagnosis and treatment of various medical conditions. His results have impacted the scientific community and the pharmaceutical and healthcare industries by illuminating new and efficient ways to synthesize chemicals. The originality of our client’s work has culminated in the authorship of several conference proceedings, 2 patents, a book chapter, and 22 peer-reviewed scientific manuscripts that were published in the top journals of his field. At the time of filing his case, his publications had been cited 424 times by researchers worldwide, demonstrating the global scientific community’s heavy reliance upon his work. Furthermore, his work has been presented and discussed at internationally renowned conferences. The major significance of his work was endorsed by an independent recommender, who stated, “[Client] has applied his extensive training in chemistry to some of the most pressing fields in medical sciences, including autoimmune diseases, cancer, and atherosclerosis. With his research, [Client] has earned a pivotal role in modern drug development and medicinal chemistry. His work will directly affect the advancement of pharmaceutical capabilities and technologies both in the United States and abroad.” With the extensive and thorough documentation that we provided, we exhibited the immeasurable value of our client’s contributions to the current state of pharmaceutical research and development. We were able to prove that our client’s social and scientific advancements and continued research have substantial merits for our country and the scientific community as a whole, thus he has served the nation to a significantly greater degree than that of others with similar education and experience. We were met with success when his NIW petition was approved in 7 months and 12 days.